16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Covalent Small Molecule Immunomodulators Targeting the Protease Active Site.
National Cancer Institute
Biological Effects of Modifications of the Englerin A Glycolate.
National Cancer Institute
Identification of a New Heterocyclic Scaffold for Inhibitors of the Polo-Box Domain of Polo-like Kinase 1.
National Cancer Institute
Novel Deazaflavin Analogues Potently Inhibited Tyrosyl DNA Phosphodiesterase 2 (TDP2) and Strongly Sensitized Cancer Cells toward Treatment with Topoisomerase II (TOP2) Poison Etoposide.
National Cancer Institute
Secondary Metabolites from the Fungus Dictyosporium sp. and Their MALT1 Inhibitory Activities.
National Cancer Institute
Characterizing the Covalent Targets of a Small Molecule Inhibitor of the Lysine Acetyltransferase P300.
National Cancer Institute
Exploiting drug-resistant enzymes as tools to identify thienopyrimidinone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H.
National Cancer Institute
Bisubstrate analog inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: new lead exhibits a distinct binding mode.
National Cancer Institute
Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: New design with improved properties.
National Cancer Institute
Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H.
National Cancer Institute
Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program.
National Cancer Institute
HIV inhibitory natural products. 26. Quinoline alkaloids from Euodia roxburghiana.
National Cancer Institute
Virtual screening application of a model of full-length HIV-1 integrase complexed with viral DNA.
National Cancer Institute